within Pharmacolibrary.Drugs.ATC.J;

model J01XD01_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0010833333333333333,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.039,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0162,
    k12             = 4.5,
    k21             = 4.5
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01XD01_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Metronidazole is a nitroimidazole antimicrobial agent used primarily to treat infections caused by anaerobic bacteria and certain parasites. It is approved for use in bacterial vaginosis, trichomoniasis, giardiasis, amebiasis, and various anaerobic infections. Metronidazole is widely used in clinical practice, both in hospital and outpatient settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters following single intravenous infusion in healthy adults.</p><h4>References</h4><ol><li><p>Fadel, C, et al., &amp; Giorgi, M (2024). Metronidazole pharmacokinetics in geese (Anser anser domesticus) after intravenous and oral administrations. <i>Journal of veterinary pharmacology and therapeutics</i> 47(3) 208–214. DOI:<a href=\"https://doi.org/10.1111/jvp.13421\">10.1111/jvp.13421</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38032073/\">https://pubmed.ncbi.nlm.nih.gov/38032073</a></p></li><li><p>van Duin, D, &amp; Bonomo, RA (2016). Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 63(2) 234–241. DOI:<a href=\"https://doi.org/10.1093/cid/ciw243\">10.1093/cid/ciw243</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27098166/\">https://pubmed.ncbi.nlm.nih.gov/27098166</a></p></li><li><p>Jumpertz, M, et al., &amp; Cassir, N (2022). Subcutaneously administered antibiotics: a review. <i>The Journal of antimicrobial chemotherapy</i> 78(1) 1–7. DOI:<a href=\"https://doi.org/10.1093/jac/dkac383\">10.1093/jac/dkac383</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36374566/\">https://pubmed.ncbi.nlm.nih.gov/36374566</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01XD01_1;
